Soc. Generale Call 50 OMV 21.06.2.../ DE000SV669Z3 /
5/31/2024 1:25:37 PM | Chg.0.000 | Bid5/31/2024 | Ask5/31/2024 | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
0.001EUR | 0.00% | 0.001 Bid Size: 25,000 |
0.020 Ask Size: 25,000 |
OMV AG | 50.00 EUR | 6/21/2024 | Call |
GlobeNewswire
3/26
Intravacc announces positive data of first in human intranasal OMV based vaccine for SARS-CoV-2
GlobeNewswire
1/16
Intravacc Awarded US$ 633K CARB-X Funding to Develop a Vaccine that Prevents Gonorrhea Infections
GlobeNewswire
9/14/2023
Intravacc Announces Review Publication of OMV-based Intranasal Vaccines for Disease Prevention
euro adhoc
10/13/2021
EANS-Adhoc: OMV Aktiengesellschaft / OMV announces redemption of the NC6 Hybrid Notes 2015 EAE
euro adhoc
7/28/2021
EANS-Tip Announcement: OMV Aktiengesellschaft / Half-year financial report according to art. 125 par...
euro adhoc
6/7/2021
EANS-DD: OMV Aktiengesellschaft / Notification concerning transactions by persons performing manager...
euro adhoc
6/7/2021
EANS-DD: OMV Aktiengesellschaft / Notification concerning transactions by persons performing manager...
euro adhoc
6/2/2021
EANS-Other capital market information: OMV Aktiengesellschaft / Acquisition and/or sale of treasury ...